Tag: in

Disparities in COVID-19 rates among adults with kidney failure in New York City

In an analysis of patients on hemodialysis in New York City, there were substantial racial/ethnic disparities in COVID-19 rates that were not explained by neighborhood social vulnerability. The findings appear in an upcoming issue of JASN. The COVID-19 pandemic has disproportionately affected socially disadvantaged groups, including Black and Hispanic individuals, those with limited English proficiency,

Deep disparities persist in who gets exposed to secondhand smoke

Harmful secondhand tobacco smoke remains more widespread than most people think, experts say, and exposure is particularly high for children, Black adults and people living below the poverty line. One of the biggest hurdles is smokers often underestimate the levels of exposure and the effects on nonsmokers’ lungs, hearts and brains. “There’s denial among the

Survey shows 3 in 4 Kiwis adopted COVID-19 protective behaviors

Research from Massey University shows an overwhelming majority of New Zealanders support regional (94 percent) or national lockdowns (81 percent) if there are new COVID-19 infections in New Zealand. In a national survey conducted by Senior Lecturer Dr. Jagadish Thaker (JT) of the School of Communication, Journalism & Marketing in February and March 2021, with

COVID vaccination in pregnancy may pass helpful antibodies to baby

Here’s reassuring news for moms-to-be: Pregnant women who receive the Pfizer-BioNTech or Moderna COVID-19 vaccines appear to transfer protective antibodies to their babies, a new study says. The researchers assessed 122 pregnant women who received the vaccines. They also analyzed the cord blood of the women’s babies at the time of birth. The helpful antibodies

How to manage osteoporosis in hematologic stem cell transplant recipients

Impaired bone health is among the most significant long-term consequences of hematopoietic stem cell transplantation (HSCT), a common therapy for patients with malignant and non-malignant hematological diseases. To address this serious problem, the International Osteoporosis Foundation (IOF) expert Working Group on Cancer and Bone Disease has published a new Executive Summary of its authoritative state-of-the-art

Indian Covid variant found in at least 17 countries: WHO

The World Health Organization said Tuesday that a variant of COVID-19 feared to be contributing to a surge in coronavirus cases in India has been found in over a dozen countries. The UN health agency said the B.1.617 variant of COVID-19 first found in India had as of Tuesday been detected in over 1,200 sequences

Significant reductions in COVID-19 infections found after single dose of Oxford-AstraZeneca and Pfizer-BioNTech vaccine

COVID-19 infections fell significantly—by 65% percent—after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study. Data from the COVID-19 Infection Survey, a partnership between the University of Oxford, the Office of National Statistics (ONS) and the Department for Health and Social Care (DHSC), is the first to show the

Chaperone protein imbalance promotes toxic tau buildup in the aging brain

Chaperone protein imbalance can play a significant role in initiating toxic accumulation of tau in the aging brain—an early step in the development of Alzheimer’s disease and related neurodegenerative disorders known as tauopathies, a new preclinical study by University of South Florida Health (USF Health) neuroscientists suggests. In humans, misfolding of the protein tau leads

SARS-CoV-2 cardiac involvement low in collegiate athletes

(HealthDay)—For U.S. collegiate athletes, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a low prevalence of cardiac involvement, according to a study published online April 17 in Circulation. Nathaniel Moulson, M.D., from Massachusetts General Hospital in Boston, and colleagues conducted a prospective, multicenter, observational cohort study to examine the prevalence, clinical characteristics,

J&J ‘very confident’ in vaccine, eyes quick resolution

Johnson & Johnson remains “very confident” in its COVID-19 vaccine and hopeful for a quick resolution from regulators over its status, a top executive said Tuesday. “We remain very confident and very hopeful that the benefit-risk profile will play out,” J&J Chief Financial Officer Joseph Wolk told CNBC. The comments came ahead of a decision